| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |